Missing molecules hold promise of therapy for pancreatic cancer: Lost microRNAs put brakes on tumors

By determining what goes missing in human cells when the gene that is most commonly mutated in pancreatic cancer gets turned on, scientists have discovered a potential strategy for therapy.